Saphnelo 300 mg/2 mL (150 mg/mL) injection Images
Generic Name: anifrolumab
This medication has been identified as Saphnelo 300 mg/2 mL (150 mg/mL) injection. It is supplied by AstraZeneca.
Saphnelo is used in the treatment of Lupus and belongs to the drug class selective immunosuppressants. Saphnelo 300 mg/2 mL (150 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Saphnelo
- Generic Name
- anifrolumab
- Strength
- 300 mg/2 mL (150 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-3040
More about Saphnelo (anifrolumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.